Similar Articles
1411 Prevention of hepatocellular carcinoma by correction of metabolic abnormalities: Role of statins and metformin
1412 Management of recurrent hepatocellular carcinoma after liver transplant
1413 Inflammation scores predict survival for hepatitis B virus-related hepatocellular carcinoma patients after transarterial chemoembolization
1414 Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy
1415 Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence
1416 Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment
1417 Assessment of radiofrequency ablation margin by MRI-MRI image fusion in hepatocellular carcinoma
1418 Inflammatory microenvironment and expression of chemokines in hepatocellular carcinoma
1419 Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients
1420 Three-dimensional morphometric analysis for hepatectomy of centrally located hepatocellular carcinoma: A pilot study
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA